Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-02-20

EMA Authorised: Palonosetron Accord (palonosetron) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised Palonosetron Accord (palonosetron) from Accord Healthcare S.L.U. for the prevention of nausea and vomiting in cancer patients, including chem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron Accord (palonosetron)

Snippet

Status: Authorised. Therapeutic area: Vomiting;Nausea;Cancer. MAH: Accord Healthcare S.L.U.. Decision date: 18/02/2026